<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-X2P6810Q</identifier><date>2009</date><creator>Jančar, Nina</creator><creator>Kocjan, Boštjan</creator><creator>Kovanda, Anja</creator><creator>Poljak, Mario</creator><creator>Seme, Katja</creator><creator>Vrtačnik-Bokal, Eda</creator><relation>documents/doc/X/URN_NBN_SI_doc-X2P6810Q_001.pdf</relation><relation>documents/doc/X/URN_NBN_SI_doc-X2P6810Q_001.txt</relation><format format_type="volume">18</format><format format_type="issue">3</format><format format_type="type">article</format><format format_type="extent">str. 94-103</format><identifier identifier_type="ISSN">1318-4458</identifier><identifier identifier_type="COBISSID">26215897</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-X2P6810Q</identifier><language>eng</language><publisher>Dermatovenerologic Society of Slovenia</publisher><source>Acta dermatovenerologica Alpina, Pannonica et Adriatica</source><rights>InC</rights><subject language_type_id="eng">Cervical Intraepithelial Neoplasia</subject><subject language_type_id="eng">Cervix Neoplasms</subject><subject language_type_id="eng">Classification</subject><subject language_type_id="slv">diagnostične metode</subject><subject language_type_id="eng">Genetics</subject><subject language_type_id="slv">Genotip</subject><subject language_type_id="eng">Genotype</subject><subject language_type_id="slv">Maternica, vrat, intraepitelijska neoplazija</subject><subject language_type_id="slv">maternični vrat</subject><subject language_type_id="slv">Maternični vrat, novotvorbe</subject><subject language_type_id="slv">novotvorbe</subject><subject language_type_id="slv">Občutljivost in specifičnost</subject><subject language_type_id="eng">Papillomavirus, Human</subject><subject language_type_id="slv">papiloma virusi</subject><subject language_type_id="slv">Papilomavirus človeški</subject><subject language_type_id="eng">Sensitivity And Specificity</subject><subject language_type_id="eng">tumor</subject><title>comparative evaluation of analytical specificity and clinical sensitivity forcervical carcinoma and CIN 3 lesions with the Hybrid capture 2 HPV DNA test</title><title>The Abbott real/time high risk HPV test</title></Record>